Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging-Reference-Cited by-同舟云学术

Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging

Published:2004-09 Issue:3 Volume:48 Page:324-332
ISSN:0004-8461
Container-title:Australasian Radiology
language:en
Short-container-title:Australas Radiol

Author:

Batra A,Tripathi RP,Singh AK

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Reference28 articles.

1. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

2. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

3. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas

4. Pre-operative grading of intracranial glioma. Comparison of MR-determined cerebral blood volume maps with thallium-201 SPECT

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Utility of Integration of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MR Perfusion Employing Split Bolus Technique in Differentiating High-Grade Glioma;Indian Journal of Radiology and Imaging;2024-01-17

2. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy;European Journal of Radiology;2023-08

3. Proliferation-dominant high-grade astrocytoma: survival benefit associated with extensive resection of FLAIR abnormality region;Journal of Neurosurgery;2020-04

4. Perfusion and permeability MRI in glioma grading;Egyptian Journal of Radiology and Nuclear Medicine;2020-01-07

5. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents;Neuroradiology;2019-02-02